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Abstract: Kartagener syndrome is a rare, ciliopathic, autosomal recessive genetic disorder that 
causes a defect in the action of the cilia lining the respiratory tract and fallopian tube. Patients 
usually present with chronic recurrent rhinosinusitis, otitis media, pneumonia, and bronchiectasis 
caused by pseudomonal infection. Situs inversus can be seen in about 50% of cases. Diagnosis 
can be made by tests to prove impaired cilia function, biopsy, and genetic studies. Treatment 
is supportive. In severe cases, the prognosis can be fatal if bilateral lung transplantation is delayed. 
We present a case of a 66-year-old woman with chronic recurrent upper respiratory infections, 
pseudomonal pneumonia, and chronic bronchiectasis who presented with acute respiratory 
failure. She was diagnosed with Kartagener syndrome based on her clinical presentation and 
genetic studies. She expired on ventilator with refractory respiratory and multiorgan failure.
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Case report
A 66-year-old woman with a past medical history of chronic recurrent rhinosinusitis, 
otitis media, hearing loss, recurrent pseudomonal pneumonia, and bronchiectasis 
presented to our hospital with a few days’ history of fever, productive cough with 
greenish phlegm, and significant shortness of breath despite being on home oxygen. 
She denied chest pain, nausea, vomiting, diarrhea, urinary symptoms, or headache. 
She was unemployed and denied any history of tobacco abuse. She had a sister who 
died of chronic progressive lung disease in her fiftieth decade.
Her vital signs were: respiratory rate, 26; oxygen saturation, 91% on 5 L of oxygen; 
blood pressure, 103/60; and temperature, 97.3 F. A physical exam revealed a frail woman 
in moderate respiratory distress with diffuse rhonchi and diminished air movement 
in both lungs. Heart sounds were more pronounced at the right sternal border. Other 
physical exam findings were unremarkable.
Her laboratory work-up was unremarkable except for mild leukocytosis and 
hypoxia. A chest X-ray revealed old bronchiectatic areas at the bases with air-fluid 
levels and new consolidation in the left mid and upper lung zones (Figure 1). The X-ray 
also revealed dextrocardia and right-sided stomach air confirming a case of situs 
inversus. She was treated with intravenous cefepime and piperacillin/tazobactam, oral 
steroids, and bronchodilators with chest physiotherapy. Since she did not improve with 
this management, bronchoscopy was performed. Alveolar lavage was negative for 
malignancy, but culture revealed positive results for Pseudomonas aeruginosa.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
42
Skeik and Jabr
A few days later, her respiratory failure deteriorated 
further and required endotracheal intubation. She remained 
on a ventilator for two weeks, then developed multiorgan 
failure which led to her death. She was diagnosed with 
Kartagener syndrome based on her clinical presentation and 
previous genetic studies that showed mutation in DNAI1 and 
DNAH5 genes.
Discussion
Immotile-cilia syndrome is a rare, ciliopathic, autosomal 
recessive genetic disorder that causes a defect in the action 
of the cilia lining the respiratory tract and fallopian tube.1 
As a result, patients usually present with chronic recurrent 
rhinosinusitis, otitis media, pneumonias, and bronchiectasis 
caused by pseudomonal infection.2 When situs inversus, 
chronic sinusitis, and bronchiectasis occur together, it is 
called Kartagener syndrome.3
Diagnosis can be made by tests to prove impaired cilia 
function, biopsy, and genetic studies.4 Measuring exhaled 
nasal nitric oxide which is mostly reduced or absent is a 
good screening test for immotile-cilia syndrome with a good 
negative predictive value.5 Mucociliary transport, which is 
reduced in these patients, can be measured in situ by admin-
istering an inhalation aerosol of colloid albumin tagged with 
99Tc.6 Electron microscopy of a nasal or bronchial biopsy 
can reveal defected cilia structure.7 Evaluation of sperm 
motility can help make the diagnosis in cases where other 
test results are equivocal. Genetic testing for mutations in the 
genes DNAI1 and DNAH5 is available through   specialized 
laboratories. If biallelic mutations are present, the test is 
diagnostic. If only one allelic mutation is found, further 
testing may identify a transallelic mutation.8
Treatment of Kartagener syndrome includes daily chest 
physiotherapy, antibiotics with good pseudomonal coverage, 
and supportive pulmonary care. The effectiveness of DNase 
and other mucolytic agents such as hypertonic saline and 
  acetylcysteine has not been fully assessed in these patients, 
but may be tried, particularly in patients with recurrent infec-
tions or ongoing respiratory symptoms.9 Surgical intervention 
for bronchiectasis is rarely recommended, but can be benefi-
cial when the disease is localized.10 Prognosis can be fatal in 
severe cases if bilateral lung transplantation is delayed.11
Differential diagnoses for immotile-cilia syndrome include 
malignancy, interstitial lung diseases including idiopathic 
pulmonary fibrosis and idiopathic interstitial   pneumonias, 
and other conditions associated with   bronchiectasis 
which include acquired (foreign body aspiration, tumor, 
  lymphadenopathy, chronic obstructive pulmonary disease, 
and mucoid   impaction) and congenital bronchial   obstruction 
(bronchomalacia, pulmonary sequestration, and yellow 
nail syndrome), recurrent infection   (immunodeficiencies), 
Figure 1 Bronchiectatic areas at the bases with air–fluid levels and new consolidation 
in left mid and upper lung zones. Dextrocardia and right-sided stomach air confirm 
a case of situs inversus.
Table 1 Differential diagnoses of Kartagener syndrome
Conditions Examples
Conditions associated with  
bronchiectasis
– Acquired obstruction Foreign body, tumor, lymphadenopathy,   
COPD, mucoid impaction, and  
connective tissue diseases
– Congenital obstruction Bronchomalacia, tracheobronchomegaly, 
ectopic bronchus, pulmonary 
sequestration, pulmonary artery 
aneurysm, and yellow nail syndrome
–   Immunodeficiency states  
with recurrent infections
IgG, IgA deficiencies, leukocyte  
dysfunction, other humoral 
immunodeficiencies
–   Abnormal secretion  
clearance
ICS, cystic fibrosis, and  
Young’s syndrome
– Miscellaneous disorders Alpha-1 antitrypsin deficiency,  
recurrent aspiration pneumonia, 
inhalation of toxic fumes and dusts,  
and chronic rejection following  
organ transplantation
– Malignancies Bronchoalveaolar carcinoma
– Interstitial Iung diseases Idiopathic pulmonary fibrosis 
Idiopathic interstitial pneumonias
Abbreviations: COPD, chronic obstructive pulmonary disease; ICS, immotile-cilia 
syndrome; IgA, immunoglobulin A; IgG, immunoglobulin G.International Journal of General Medicine
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abnormal secretion disorder (cystic fibrosis), and other 
  miscellaneous conditions (alpha-1 antitrypsin deficiency and 
connective tissue disease) (Table 1).1,12–15
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